Journal profile · Medicine-Transplantation
Renal Replacement Therapy
ISSN 2059-1381 · Springer Nature · United Kingdom
Renal Replacement Therapy: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.4 (journal website); diamond open access (no APC); no APC; median 90 days to acceptance (100 articles, last 24 months); 102 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Renal Replacement Therapy is published by Springer Nature and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dialysis and Renal Disease Management, Central Venous Catheters and Hemodialysis and Acute Kidney Injury Research, together about 45.4% of its articles. Its main subfields are Nephrology. (generated from OpenAlex topic counts and CAS ranking data)
Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy. RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Transplantation
Editor-in-chief Masanori AbePublisher website
Editorial board by country: 3 in mainland China (about 6%); most named Japan 40, Mainland China 3, Taiwan, China 3, United States 2, Hong Kong, China 1 (50 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dialysis and Renal Disease ManagementMedicine30%
- Central Venous Catheters and HemodialysisHealth Professions8.1%
- Acute Kidney Injury ResearchMedicine7.2%
- Muscle and Compartmental DisordersMedicine7%
- Chronic Kidney Disease and DiabetesMedicine5%
- Parathyroid Disorders and TreatmentsMedicine4.1%
- Erythropoietin and Anemia TreatmentMedicine4%
- Renal Transplantation Outcomes and TreatmentsMedicine2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
CASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 1.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.2Publisher website ·
- CiteScore 2026-06
- 1.5LetPub ·
- SJR 2026-06
- 0.36LetPub ·
- SNIP 2026-06
- 0.61LetPub ·
- h-index
- 31OpenAlex ·
- i10-index
- 143OpenAlex ·
- 2-year mean citedness
- 1.48OpenAlex ·
- Self-citation rate
- 7.1%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 99LetPub ·
- Downloads per year (publisher) 2025
- 596,800Publisher website ·
Articles by year OpenAlex count · 762 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 73 | 73 | 8 |
| 2025 | 102 | 102 | 100 |
| 2024 | 78 | 78 | 267 |
| 2023 | 63 | 63 | 312 |
| 2022 | 64 | 64 | 295 |
| 2021 | 70 | 70 | 519 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
90 daysMedian, submission to acceptance · P25–P75 66 days – 132 days
- Acceptance to online
- median 18 days (102 articles)
- Submission to online
- median 109 days
- Sample
- 100 articles with submission and acceptance dates (193 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 19 weeksLetPub ·
- Submission to first decision
- 7 daysPublisher website ·
- Submission to publication (journal-reported)
- about 19 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY, CC0 | |
| OpenAlex | USD 0 | — | — | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2059-1381
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Renal Replacement Therapy
What CAS zone is Renal Replacement Therapy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Renal Replacement Therapy is in Zone 4 of Medicine, and in Zone 4 of the minor category Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Renal Replacement Therapy?
The journal's website gives an impact factor of 1.4 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 1.5, h-index 31.
How long does peer review take at Renal Replacement Therapy?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 90 days (interquartile range 66–132 days); authors report an average review time of about 19 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Renal Replacement Therapy based?
Of the 50 board members whose country the journal's board page names, 3 (about 6%) are in mainland China; the countries named most often are Japan (40), Mainland China (3) and Taiwan, China (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Renal Replacement Therapy?
According to LetPub and DOAJ records, Renal Replacement Therapy is indexed in ESCI, Scopus and DOAJ. The journal's website also lists CAS; that list has not been checked against each database.
Is Renal Replacement Therapy open access, and what is the APC?
Renal Replacement Therapy is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .